[1] Surewaard BGJ, Thanabalasuriar A, Zeng Z, et al. α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis. Cell Host Microbe, 2018, 24:271-284.
[2] 吴英林, 赵晓琴, 覃桦. ICU脓毒症相关性肝损伤的临床研究. 中国临床医生杂志, 2018, 46:538-540.
[3] 易钊泉, 范春. 脓毒症肝损伤的临床研究. 胃肠病学和肝病学杂志, 2017, 26:199-202.
[4] 魏军, 王艳红, 蒋金辉, 等. 血必净注射液联合乌司他丁对脓毒症患者血清因子、T细胞亚群及D-二聚体的影响. 药物评价研究, 2018, 41:1077-1081.
[5] 寇夕, 刘虹. 乌司他丁通过p38丝裂原活化蛋白激酶通路治疗大鼠脓毒症急性肝损伤的相关性研究. 中华危重症医学杂志(电子版), 2017, 10:309-315.
[6] 姚咏明, 盛志勇, 林洪远. 2001 年国际脓毒症定义会议关于脓毒症诊断的新标准. 2006, 18:645-645.
[7] 孙宁, 栾正刚. 脓毒症合并肝损伤的诊断与治疗研究进展. 中国临床新医学, 2018, 11:294-298.
[8] Chen X, Cai X, Le R, et al. Isoliquiritigenin protects against sepsis-induced lung and liver injury by reducing inflammatory responses. Biochem Biophys Res Commun, 2018, 496:245-252.
[9] Savio LEB, de Andrade Mello P, Figliuolo VR, et al. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. J Hepatol, 2017, 67:716-726.
[10] 邱荣宗, 姚伟峰, 沙伟萍, 等. 白藜芦醇对脓毒症大鼠NF-κB/IκB调节机制的研究.临床和实验医学杂志, 2018, 17:1581-1584.
[11] Xu Q, Yan Q, Chen S. Ulinastatin is effective in reducing mortality for critically ill patients with sepsis: a causal mediation analysis. Sci Rep, 2018, 8:14360-14364.
[12] Cao C, Yin C, Chai Y, et al. Ulinastatin mediates suppression of regulatory T cells through TLR4/NF-κB signaling pathway in murine sepsis. Int Immunopharmacol, 2018, 64:411-423. |
